5.07
price up icon5.41%   0.26
pre-market  プレマーケット:  5.07  
loading

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
Mar 04, 2026

Market Fear: Whats the profit margin of CytomX Therapeutics IncWeekly Stock Recap & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

Risk Report: Whats the profit margin of CytomX Therapeutics IncJuly 2025 News Drivers & Community Consensus Stock Picks - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - Bitget

Mar 04, 2026
pulisher
Mar 04, 2026

Kynam Capital files 5.29% stake in CytomX (NASDAQ: CTMX) - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

CytomX Therapeutics Target of Unusually High Options Trading (NASDAQ:CTMX) - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

CytomX Therapeutics, Inc. to Announce Full Year 2025 Financial Results on March 16, 2026 - Quiver Quantitative

Mar 04, 2026
pulisher
Mar 02, 2026

CTMX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

CytomX Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Mar 02, 2026
pulisher
Feb 26, 2026

CytomX Therapeutics, Inc. (CTMX): Investor Outlook Reveals 55.71% Potential Upside - DirectorsTalk Interviews

Feb 26, 2026
pulisher
Feb 26, 2026

CTMXCytomx Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings Recap: Is CytomX Therapeutics Inc a good ESG investment2025 Stock Rankings & Proven Capital Preservation Methods - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 26, 2026

CytomX Therapeutics (CTMX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 26, 2026
pulisher
Feb 23, 2026

Is CytomX Therapeutics Inc stock showing strong momentumJuly 2025 Sector Moves & Low Risk High Reward Ideas - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 21, 2026

Will CytomX Therapeutics Inc. (6C1) stock rise with strong economyWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru

Feb 21, 2026
pulisher
Feb 19, 2026

Unmasking CytomXA Pioneer In Masked Therapeutics - RTTNews

Feb 19, 2026
pulisher
Feb 17, 2026

Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating - Finviz

Feb 17, 2026
pulisher
Feb 17, 2026

Tang Capital reports 0% CytomX (CTMX) stake in latest 13G/A filing - Stock Titan

Feb 17, 2026
pulisher
Feb 15, 2026

Is CytomX Therapeutics Inc. stock positioned well for digital economyDip Buying & Real-Time Buy Signal Notifications - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

CTMX Should I Buy - Intellectia AI

Feb 15, 2026
pulisher
Feb 14, 2026

Is CytomX Therapeutics Inc. (6C1) stock a fit for income portfolios2025 Buyback Activity & Expert Curated Trade Setups - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Will CytomX Therapeutics Inc. stock benefit from infrastructure spendingJuly 2025 Big Picture & Entry Point Strategy Guides - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Can CytomX Therapeutics Inc. disrupt its industryEarnings Recap Summary & Fast Entry Momentum Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Market Trends: What hedge funds are buying CytomX Therapeutics Inc2025 Fundamental Recap & AI Enhanced Trading Signals - baoquankhu1.vn

Feb 14, 2026
pulisher
Feb 14, 2026

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 14, 2026
pulisher
Feb 13, 2026

Quarterly Recap: Is CytomX Therapeutics Inc benefiting from interest rate changesMarket Sentiment Report & Technical Pattern Based Buy Signals - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

CytomX Therapeutics, Inc. (CTMX) Investor Outlook: A Biotech Pioneer with a 61.87% Potential Upside - DirectorsTalk Interviews

Feb 12, 2026
pulisher
Feb 12, 2026

CytomX Therapeutics Conference: CFO Highlights Varseta-M CRC Response Data, Next Catalysts - MarketBeat

Feb 12, 2026
pulisher
Feb 11, 2026

FMR LLC's Strategic Acquisition of CytomX Therapeutics Inc Shares - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

CytomX at Guggenheim Summit: Promising CRC Treatment Path By Investing.com - Investing.com Canada

Feb 11, 2026
pulisher
Feb 11, 2026

Stock Recap: Is CytomX Therapeutics Inc benefiting from interest rate changes2025 Institutional Moves & Capital Protection Trade Alerts - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

How New Analyst Assumptions Are Rewriting The Story For CytomX Therapeutics (CTMX) - Yahoo Finance

Feb 11, 2026
pulisher
Feb 10, 2026

CTMX: Masked ADC shows 28% response in late-line CRC; registrational study planned by 2027 - TradingView

Feb 10, 2026
pulisher
Feb 08, 2026

Rally Mode: Can CytomX Therapeutics Inc navigate macro headwindsJuly 2025 PreEarnings & High Yield Equity Trading Tips - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

CytomX Therapeutics2026 Funding Rounds & List of Investors - Tracxn

Feb 07, 2026
pulisher
Feb 07, 2026

Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX) - The Globe and Mail

Feb 07, 2026
pulisher
Feb 06, 2026

Analysts bullish ahead of colorectal cancer readout for CytomX Therapeutics, Inc. (CTMX) - MSN

Feb 06, 2026
pulisher
Feb 05, 2026

CytomX Therapeutics, Inc. (CTMX) Investor Outlook: Exploring a 58.73% Potential Upside Amid Innovative Oncology Developments - DirectorsTalk Interviews

Feb 05, 2026
pulisher
Feb 05, 2026

Analysis Recap: Whats the profit margin of CytomX Therapeutics IncWeekly Trend Summary & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

Will CytomX Therapeutics Inc. (6C1) stock outperform foreign stocksJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - mfd.ru

Feb 05, 2026
pulisher
Feb 04, 2026

CytomX Therapeutics (CTMX) Price Target Increased by 20.20% to 8.67 - Nasdaq

Feb 04, 2026
pulisher
Feb 04, 2026

Cantor Fitzgerald Raises Price Target for CytomX Therapeutics (C - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Cantor Fitzgerald Raises CytomX Therapeutics (NASDAQ:CTMX) Price Target to $10.00 - MarketBeat

Feb 04, 2026
pulisher
Feb 04, 2026

CTMX: Barclays Analyst Raises Price Target to $10.00 | CTMX Stock News - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

CytomX Therapeutics to Present at Upcoming February Conferences - 富途牛牛

Feb 04, 2026
pulisher
Feb 04, 2026

CytomX Therapeutics price target raised to $10 from $8 at Barclays - TipRanks

Feb 04, 2026
pulisher
Feb 03, 2026

A Look At CytomX Therapeutics (CTMX) Valuation After Optimistic Analyst Target Hikes On Phase 1 Cancer Data - Sahm

Feb 03, 2026
pulisher
Feb 03, 2026

CytomX Therapeutics stock hits 52-week high at 6.16 USD By Investing.com - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year HighHere's Why - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

CytomX Therapeutics stock hits 52-week high at 6.16 USD - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed? - Yahoo Finance

Feb 03, 2026
pulisher
Feb 02, 2026

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) - Insider Monkey

Feb 02, 2026
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):